Segment & Geographic Data
Quant-Grade Normalized (live API)
API & CSV Delivery
Histogen Inc's Business Segments
Histogen Inc's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.
Segment Data As of FY
Reportable Segments
-
Largest Segment
-
Total Revenue
$ 0
Regions Reported
-
Histogen Inc does not report a distinct business-segment axis in its filings - its disaggregated revenue is disclosed by product and service category instead. See the Product & Service breakdown below.
Revenue by Product & Service Category - FY
- License100%
Revenue by Product & Service Category - FY
| Category | Revenue (Millions) | % of Total |
|---|---|---|
| License | $ 0 | 100% |
Product and service categories are a supplemental disclosure and are not required to sum to consolidated revenue or to the reportable segments above.
Description of Histogen Inc
Histogen Inc. is a regenerative medicine company that focuses on developing innovative therapies to address various medical and aesthetic conditions. The company specializes in the development of products based on its proprietary platform technology, Histogen's Extracellular Matrix (ECM) products.
The ECM products are created by culturing newborn fibroblasts, a type of skin cell, in a three-dimensional environment. This process stimulates the cells to produce a unique combination of proteins, growth factors, and other biomolecules that mimic the embryonic conditions in which tissues develop. These ECM products have shown great potential in promoting tissue regeneration and cellular rejuvenation.
One of Histogen's key product candidates is HSC, or Hair Stimulating Complex. HSC is designed to stimulate the growth of new hair follicles and improve the overall thickness and density of existing hair. This product has undergone several clinical trials and has shown promising results in both men and women with androgenetic alopecia (pattern baldness).
Histogen is also developing a range of other applications for its ECM technology. These include skin rejuvenation, wound healing, and orthopedic indications. The company's ECM products have demonstrated the ability to stimulate the production of collagen and other extracellular matrix components, which are essential for tissue repair and regeneration.
In addition to its technology platform, Histogen has a strong intellectual property portfolio with numerous granted and pending patents. This provides the company with a competitive advantage and allows it to protect its innovations and market exclusivity.
Histogen collaborates with various research institutions, universities, and industry partners to advance its product pipeline. The company has forged partnerships with leading medical centers and commercial organizations to conduct clinical trials and bring its products to market.
Overall, Histogen Inc. is a regenerative medicine company at the forefront of developing innovative therapies based on its proprietary ECM technology. With a focus on tissue regeneration and cellular rejuvenation, the company aims to address unmet medical needs in a wide range of applications, including hair loss, skin rejuvenation, wound healing, and orthopedics.
The ECM products are created by culturing newborn fibroblasts, a type of skin cell, in a three-dimensional environment. This process stimulates the cells to produce a unique combination of proteins, growth factors, and other biomolecules that mimic the embryonic conditions in which tissues develop. These ECM products have shown great potential in promoting tissue regeneration and cellular rejuvenation.
One of Histogen's key product candidates is HSC, or Hair Stimulating Complex. HSC is designed to stimulate the growth of new hair follicles and improve the overall thickness and density of existing hair. This product has undergone several clinical trials and has shown promising results in both men and women with androgenetic alopecia (pattern baldness).
Histogen is also developing a range of other applications for its ECM technology. These include skin rejuvenation, wound healing, and orthopedic indications. The company's ECM products have demonstrated the ability to stimulate the production of collagen and other extracellular matrix components, which are essential for tissue repair and regeneration.
In addition to its technology platform, Histogen has a strong intellectual property portfolio with numerous granted and pending patents. This provides the company with a competitive advantage and allows it to protect its innovations and market exclusivity.
Histogen collaborates with various research institutions, universities, and industry partners to advance its product pipeline. The company has forged partnerships with leading medical centers and commercial organizations to conduct clinical trials and bring its products to market.
Overall, Histogen Inc. is a regenerative medicine company at the forefront of developing innovative therapies based on its proprietary ECM technology. With a focus on tissue regeneration and cellular rejuvenation, the company aims to address unmet medical needs in a wide range of applications, including hair loss, skin rejuvenation, wound healing, and orthopedics.
Histogen Inc. is a regenerative medicine company that focuses on developing therapeutic products derived from its proprietary cell culture technology. The company primarily targets areas such as dermatology, orthopedics, and hair restoration through various innovative products and services. Below are the key segments, products, and services that Histogen Inc. offers:
Segments
1. Dermatology and Aesthetic Medicine:
- Histogens products in this segment are designed to improve skin health and appearance, targeting issues such as aging, scarring, and hair loss.
2. Orthopedics:
- This segment focuses on the development of regenerative therapies to enhance healing and recovery of musculoskeletal tissues, including cartilage and bone.
3. Hair Restoration:
- Histogen aims to provide treatments for hair loss by utilizing its technology to stimulate hair growth and improve overall scalp health.
Products
1. HST 001:
- Overview: This product is designed for the treatment of androgenetic alopecia (pattern hair loss).
- Mechanism: It contains a formulation of growth factors and proteins that are derived from human fibroblast cells, which aim to rejuvenate hair follicles and stimulate new hair growth.
- Applications: It is primarily used for both male and female patients experiencing hair loss.
2. HST 002:
- Overview: This product targets skin aging and involves the use of growth factors to improve skin elasticity and firmness.
- Mechanism: HST 002 includes a complex mixture of proteins and other biomolecules that promote skin cell regeneration and collagen production.
- Applications: Designed for cosmetic use, it addresses fine lines, wrinkles, and overall skin texture.
3. HST 003:
- Overview: Developed for orthopedic applications, especially focusing on joint health and cartilage repair.
- Mechanism: This product utilizes regenerative factors to enhance healing in damaged tissues and improve joint function.
- Applications: Applicable in conditions such as osteoarthritis and sports-related injuries.
4. HST 004:
- Overview: This product is dedicated to treating hypertrophic scars and keloids.
- Mechanism: It employs specific growth factors to modulate the healing process and minimize excessive scar formation.
- Applications: Used in both surgical and non-surgical cases to improve aesthetic outcomes.
Services
1. Clinical Research and Development:
- Histogen engages in comprehensive clinical trials to evaluate the safety and efficacy of its products. The company is committed to following stringent regulatory pathways to ensure that its therapies meet industry standards.
2. Contract Manufacturing:
- Histogen offers services related to the manufacturing of its regenerative products, adhering to Good Manufacturing Practices (GMP) to ensure quality and consistency in production.
3. Consultation and Training:
- The company provides consultation services to healthcare professionals interested in adopting regenerative therapies. This includes training on the application of their products and understanding the underlying science.
4. Collaboration and Partnerships:
- Histogen actively seeks partnerships with research institutions, universities, and other organizations to foster innovation and expand the reach of its technologies and services.
5. Education and Outreach:
- Histogen conducts educational initiatives to inform both healthcare providers and potential patients about the benefits of regenerative medicine, aiming to enhance awareness and understanding of their product offerings.
Conclusion
Histogen Inc. is positioned at the forefront of regenerative medicine, with a diverse array of products targeting various applications in dermatology, orthopedics, and hair restoration. By leveraging its proprietary technologies, the company aims to provide innovative solutions that improve patient outcomes and enhance quality of life. The services offered further extend their impact in the medical community, driving both research and clinical application.
Segments
1. Dermatology and Aesthetic Medicine:
- Histogens products in this segment are designed to improve skin health and appearance, targeting issues such as aging, scarring, and hair loss.
2. Orthopedics:
- This segment focuses on the development of regenerative therapies to enhance healing and recovery of musculoskeletal tissues, including cartilage and bone.
3. Hair Restoration:
- Histogen aims to provide treatments for hair loss by utilizing its technology to stimulate hair growth and improve overall scalp health.
Products
1. HST 001:
- Overview: This product is designed for the treatment of androgenetic alopecia (pattern hair loss).
- Mechanism: It contains a formulation of growth factors and proteins that are derived from human fibroblast cells, which aim to rejuvenate hair follicles and stimulate new hair growth.
- Applications: It is primarily used for both male and female patients experiencing hair loss.
2. HST 002:
- Overview: This product targets skin aging and involves the use of growth factors to improve skin elasticity and firmness.
- Mechanism: HST 002 includes a complex mixture of proteins and other biomolecules that promote skin cell regeneration and collagen production.
- Applications: Designed for cosmetic use, it addresses fine lines, wrinkles, and overall skin texture.
3. HST 003:
- Overview: Developed for orthopedic applications, especially focusing on joint health and cartilage repair.
- Mechanism: This product utilizes regenerative factors to enhance healing in damaged tissues and improve joint function.
- Applications: Applicable in conditions such as osteoarthritis and sports-related injuries.
4. HST 004:
- Overview: This product is dedicated to treating hypertrophic scars and keloids.
- Mechanism: It employs specific growth factors to modulate the healing process and minimize excessive scar formation.
- Applications: Used in both surgical and non-surgical cases to improve aesthetic outcomes.
Services
1. Clinical Research and Development:
- Histogen engages in comprehensive clinical trials to evaluate the safety and efficacy of its products. The company is committed to following stringent regulatory pathways to ensure that its therapies meet industry standards.
2. Contract Manufacturing:
- Histogen offers services related to the manufacturing of its regenerative products, adhering to Good Manufacturing Practices (GMP) to ensure quality and consistency in production.
3. Consultation and Training:
- The company provides consultation services to healthcare professionals interested in adopting regenerative therapies. This includes training on the application of their products and understanding the underlying science.
4. Collaboration and Partnerships:
- Histogen actively seeks partnerships with research institutions, universities, and other organizations to foster innovation and expand the reach of its technologies and services.
5. Education and Outreach:
- Histogen conducts educational initiatives to inform both healthcare providers and potential patients about the benefits of regenerative medicine, aiming to enhance awareness and understanding of their product offerings.
Conclusion
Histogen Inc. is positioned at the forefront of regenerative medicine, with a diverse array of products targeting various applications in dermatology, orthopedics, and hair restoration. By leveraging its proprietary technologies, the company aims to provide innovative solutions that improve patient outcomes and enhance quality of life. The services offered further extend their impact in the medical community, driving both research and clinical application.